Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideLLYLilly (Eli)
FinDog View：Bullish
| Metric | LLY | MRNA |
|---|
| Close | 1,417.54 | 221.72 |
| Market Cap | $1.34T | $88.3B |
| 1M | +22.51% | +15.14% |
| P/E (TTM) | 50.2 | — |
| Forward P/E | 26.3 | — |
| P/E 5-Yr Percentile | 28 | — |
| P/S | 16.8 | 39.7 |
| P/B | 39.6 | 13.1 |
| Dividend Yield | 0.75% | — |
| Latest Quarter Revenue | $24.4B | $145M |
| Revenue YoY | +38.6% | +2.1% |
| Gross Margin | 83.9% | 35.9% |
| Latest Quarter EPS | 7.22 | -1.97 |
| Avg Post-Earnings Move | ±3.5% | ±4.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 0.88% | — |
| 90-Day Net Insider Buying | −$16.0M | −$62.6M |
LLY · Revenue, Last 8 Quarters ($B)
MRNA · Revenue, Last 8 Quarters ($B)
